Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows a 403 Forbidden error with the site header and footer, indicating the study record is temporarily unavailable.SummaryDifference20%

- Check38 days agoChange DetectedTwo new literature citations were added to the study record, including Hansen et al. and Wong & Yee, documenting recent research on T cell responses and polyomavirus-positive Merkel cell carcinoma.SummaryDifference0.1%

- Check52 days agoChange DetectedFooter now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5; this reflects a site-wide version update rather than a change to the study details.SummaryDifference0.0%

- Check74 days agoChange DetectedAn updated revision tag from v3.6.4 to v3.6.5 is displayed on the page, indicating a newer version of the study document.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.